<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl5" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Group 1</th><th>Group 2</th><th>Effect size d</th><th>A priori power</th><th>Group 1 sample size</th><th>Group 2 sample size</th></tr></thead><tbody><tr><td>CB17/G12V/Day 6</td><td>CB17/G12V/Day 30</td><td>5.068197</td><td>96.5%<xref ref-type="table-fn" rid="tblfn2">*</xref></td><td>3<xref ref-type="table-fn" rid="tblfn2">*</xref></td><td>3<xref ref-type="table-fn" rid="tblfn2">*</xref></td></tr><tr><td>CB17/G12V/Day 6</td><td>SCIDBeige/G12V/Day 30</td><td>5.498927</td><td>98.3%<xref ref-type="table-fn" rid="tblfn2">*</xref></td><td>3<xref ref-type="table-fn" rid="tblfn2">*</xref></td><td>3<xref ref-type="table-fn" rid="tblfn2">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><label>*</label><p>Five in each group will be used based on the p21 planned comparison calculations making the power 99.9%.</p></fn></table-wrap-foot></table-wrap>